logo

LXRX

Lexicon Pharmaceuticals
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

LXRX fundamentals

Lexicon Pharmaceuticals (LXRX) expects to report earnings on Aug 7, 2025, with estimated revenue of 4.87M (YoY +195.15%), and EPS at -0.08 (YoY +52.94%).
Revenue estimate / YoY
4.87M
+195.15%
EPS estimate / YoY
-0.08
+52.94%
Report date
Aug 7, 2025
EPS
Revenue

Revenue & Expenses

LXRX has released its 2025 Q1 earnings report, with revenue of 1.26M, reflecting a YoY change of 11.68%, and net profit of -25.30M, showing a YoY change of 47.73%. The Sankey diagram below clearly presents LXRX's revenue sources and cost distribution.

Key Indicators

Lexicon Pharmaceuticals (LXRX) key financial stats and ratios, covering profitability, financial health, and leverage.
Lexicon Pharmaceuticals (LXRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Lexicon Pharmaceuticals (LXRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Lexicon Pharmaceuticals (LXRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Lexicon Pharmaceuticals (LXRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Lexicon Pharmaceuticals (LXRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield